2023-02-01 08:06:36 AGRX Agile Therapeutics
02/01/23 02/0108:06 02/01/2308:06 | Agile Therapeutics provides clinical update on Twirla, pipeline evaluationAgile Therapeutics provided an update on the Twirla post-marketing studies and status of its ongoing evaluation of the Company's pipeline. Twirla Post-Marketing Studies: As part of Twirla's approval, the United States Food and Drug Administration required the Company to conduct a long-term prospective, multi-center clinical post-marketing requirement study comparing the risks of venous thromboembolism and arterial thromboembolism in new users of Twirla to new users of combined hormonal contraceptives and Ortho Evra generic patches. In January 2023, the FDA agreed with the Company's proposal to address this PMR using electronic health records and insurance claims from a large database from multiple healthcare systems. The FDA also agreed to extend the study timelines. Under these new milestones, interim safety data reporting to the FDA is due in November 2029, and the final PMR study report is scheduled to be submitted to the FDA in November 2035. Status of Pipeline Evaluation: As previously disclosed, all work on Agile's pipeline has been halted since 2021 as the Company concentrates its efforts the commercialization of Twirla. Commercializing Twirla remains the Company's primary focus into 2023; however, the Company has continued to evaluate the potential eventual advancement of the AG200-15 Extended Regimen and the progestin-only patch. "Our primary focus since the launch of Twirla has been the commercial growth of Twirla. We believe, however, that we have potential value in our pipeline and have been evaluating how to prioritize the eventual development of our product candidates. While we do not currently expect to invest significant funds in our pipeline in 2023 as we continue to focus on maintaining capital efficiency and keeping tight control on our operating expenses, we have been using creative approaches to advance the evaluation of our pipeline and prepare for a time when we can move forward," stated, Al Altomari, Chairman and Chief Executive Officer of Agile Therapeutics.As part of its evaluation of the AG200-15 Extended Regimen, Agile performed an analysis with a simulated pharmacokinetic model that was used to predict the systemic levonorgestrel and ethinyl estradiol exposure of Twirla if used for twelve consecutive weeks. Data from a previously published clinical phase 1, open-label, randomized clinical trial2 was used for the PK model simulation, which included 36 healthy individuals who used a standard Twirla regimen for three consecutive weeks. |
---|
General news
|
Treasury's $15 B 10-year TIPS reopening was rather tepid »
13:35 03/23/23 03/2313:35 03/23/2313:35
$ECON
Economic Data
Treasury's $15 B… Story temporarily locked. ShowHide Related Items >><<
|
Options
|
Futu Holdings put volume heavy and directionally bearish »
13:35 03/23/23 03/2313:35 03/23/2313:35
FUTU
Futu Holdings
Bearish flow noted in… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Block exploring legal action against Hindenburg after 'misleading' report »
13:34 03/23/23 03/2313:34 03/23/2313:34
SQ
Block
Block said in a… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Block calls Hindenburg report 'factually inaccurate and misleading'
13:33 03/23/23 03/2313:33 03/23/2313:33
SQ
Block
ShowHide Related Items >><<
|
Conference/Events
|
BioLife Solutions to host virtual analyst day »
13:25 03/23/23 03/2313:25 03/23/2313:25
BLFS
BioLife Solutions
Virtual Analyst Day to be… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Home Point 'closer to being sold,' Inside Mortgage Finance says »
13:20 03/23/23 03/2313:20 03/23/2313:20
HMPT
Home Point Capital
Home Point Capital is… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Freight Technologies announces 10-for-1 reverse share split »
13:17 03/23/23 03/2313:17 03/23/2313:17
FRGT
Freight Technologies
Freight Technologies… Story temporarily locked. ShowHide Related Items >><<
|
Technical Analysis
|
NASDAQ market internals summary »
13:17 03/23/23 03/2313:17 03/23/2313:17
$NSD
NASDAQ Market Internals
Volume is above average… Story temporarily locked. ShowHide Related Items >><<
|
Technical Analysis
| Volume is above average… Story temporarily locked. ShowHide Related Items >><<
|
General news
| Total Amount: $15B, Rate:… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
FiscalNote selected as inaugural 'trusted partner' for OpenAI's ChatGPT plug-in »
13:04 03/23/23 03/2313:04 03/23/2313:04
NOTE
FiscalNote
FiscalNote announced it… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Lapse in Boeing credentials for Air Force One probed by Pentagon, WSJ says »
13:02 03/23/23 03/2313:02 03/23/2313:02
BA
Boeing
The Pentagon is examining… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Portfolio Recovery Associates announces settlement of CFPB matter »
12:52 03/23/23 03/2312:52 03/23/2312:52
PRAA
PRA Group
PRA Group announced that… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Par Technology management to meet with Needham »
12:48 03/23/23 03/2312:48 03/23/2312:48
PAR
Par Technology
Meeting to be held in New… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
ABB announces new $1B share buyback program »
12:45 03/23/23 03/2312:45 03/23/2312:45
ABB
ABB
ABB said its board… Story temporarily locked. ShowHide Related Items >><<
|
Options
|
GSK Pharma call volume above normal and directionally bullish »
12:45 03/23/23 03/2312:45 03/23/2312:45
GSK
GSK
Bullish option flow… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Cara Therapeutics management to meet virtually with Needham »
12:44 03/23/23 03/2312:44 03/23/2312:44
CARA
Cara Therapeutics
Virtual Meeting to be… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Zuora management to meet with Needham »
12:43 03/23/23 03/2312:43 03/23/2312:43
ZUO
Zuora
Meeting to be held in… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Essential Properties price target lowered to $27 from $28 at Ladenburg »
12:38 03/23/23 03/2312:38 03/23/2312:38
EPRT
Essential Properties Realty Trust
Ladenburg analyst John… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Stride management to meet with Barrington »
12:37 03/23/23 03/2312:37 03/23/2312:37
LRN
Stride
Meetings to be held in… Story temporarily locked. ShowHide Related Items >><<
|
Options
|
Western Alliance put volume heavy and directionally bearish »
12:35 03/23/23 03/2312:35 03/23/2312:35
WAL
Western Alliance
Bearish flow noted in… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Quarterhill price target lowered to C$2 at Raymond James »
12:31 03/23/23 03/2312:31 03/23/2312:31
QTRHF
Quarterhill
Raymond James analyst… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Robert Half names Susan Haseley chief ESG and DEI officer »
12:30 03/23/23 03/2312:30 03/23/2312:30
RHI
Robert Half
Robert Half has promoted… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
ECN Capital price target lowered to C$4 at Raymond James »
12:30 03/23/23 03/2312:30 03/23/2312:30
ECNCF
ECN Capital
Raymond James lowered the… Story temporarily locked. ShowHide Related Items >><<
|
Syndicate
|
CBL International opens at $4.21, IPO priced at $4 »
12:27 03/23/23 03/2312:27 03/23/2312:27
BANL
CBL International
CBL International is a… Story temporarily locked. ShowHide Related Items >><<
|